H.R. 9421: To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.
Sponsors
6 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Jun. 24, 2026 | Introduced in House |
| Jun. 24, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.